Luca Lalli

971 total citations
17 papers, 330 citations indexed

About

Luca Lalli is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Luca Lalli has authored 17 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Luca Lalli's work include Cancer Immunotherapy and Biomarkers (6 papers), Immune cells in cancer (5 papers) and Renal cell carcinoma treatment (4 papers). Luca Lalli is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Immune cells in cancer (5 papers) and Renal cell carcinoma treatment (4 papers). Luca Lalli collaborates with scholars based in Italy, United States and Qatar. Luca Lalli's co-authors include Paolo Bruzzi, Sergio Bertoglio, Ferdinando Cafiero, Luigi Mariani, Veronica Huber, Licia Rivoltini, Giuseppe Procopio, Elena Verzoni, Anna Maria Frezza and Pierangela Sepe and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Luca Lalli

15 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luca Lalli Italy 8 148 94 89 59 58 17 330
José Mariz Portugal 11 66 0.4× 93 1.0× 89 1.0× 19 0.3× 16 0.3× 41 362
J.-L. Houpeau France 7 63 0.4× 89 0.9× 8 0.1× 47 0.8× 51 0.9× 8 271
Shunsuke Sugawara Japan 11 134 0.9× 32 0.3× 15 0.2× 27 0.5× 19 0.3× 63 337
Andrew Adamson United Kingdom 9 82 0.6× 20 0.2× 25 0.3× 24 0.4× 19 0.3× 27 308
Barry Hutchinson Ireland 8 149 1.0× 10 0.1× 78 0.9× 42 0.7× 60 1.0× 16 357
Güngör Utkan Türkiye 9 85 0.6× 30 0.3× 47 0.5× 8 0.1× 26 0.4× 57 308
Jong Kil Nam South Korea 11 239 1.6× 16 0.2× 82 0.9× 78 1.3× 29 0.5× 50 483
Joanna Rupa‐Matysek Poland 11 20 0.1× 40 0.4× 24 0.3× 21 0.4× 13 0.2× 43 392
V. Milesi Italy 2 39 0.3× 25 0.3× 33 0.4× 9 0.2× 15 0.3× 3 252
Pegge Halandras United States 12 202 1.4× 19 0.2× 44 0.5× 10 0.2× 13 0.2× 40 395

Countries citing papers authored by Luca Lalli

Since Specialization
Citations

This map shows the geographic impact of Luca Lalli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Lalli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Lalli more than expected).

Fields of papers citing papers by Luca Lalli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Lalli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Lalli. The network helps show where Luca Lalli may publish in the future.

Co-authorship network of co-authors of Luca Lalli

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Lalli. A scholar is included among the top collaborators of Luca Lalli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Lalli. Luca Lalli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Stellato, Marco, Pierangela Sepe, Enrico Bronte, et al.. (2025). Real-life Use of Cabozantinib in Front-line therapy for Metastatic Renal Cell Carcinoma: The CabFRONT Study (Meet-URO 24). European Urology Open Science. 82. 1–7.
2.
3.
Bogani, Giorgio, Luca Lalli, Jvan Casarin, et al.. (2024). Predicting the Risk of nOdal disease with histological and Molecular features in Endometrial cancer: the prospective PROME trial. International Journal of Gynecological Cancer. 34(9). 1366–1372. 12 indexed citations
4.
5.
Daveri, Elena, Luca Sorrentino, Luca Lalli, et al.. (2022). Low baseline neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict increased overall survival in locally recurrent rectal cancer despite R1 margins. Digestive and Liver Disease. 54(7). 864–870. 4 indexed citations
6.
Procopio, Giuseppe, Pierangela Sepe, Mélanie Claps, et al.. (2022). Cabozantinib as First-line Treatment in Patients With Metastatic Collecting Duct Renal Cell Carcinoma. JAMA Oncology. 8(6). 910–910. 43 indexed citations
7.
Rinchai, Darawan, Elena Verzoni, Veronica Huber, et al.. (2021). Integrated transcriptional‐phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patients. SHILAP Revista de lepidopterología. 11(6). e434–e434. 5 indexed citations
8.
Vergani, Elisabetta, Elena Daveri, Viviana Vallacchi, et al.. (2021). Extracellular vesicles in anti-tumor immunity. Seminars in Cancer Biology. 86(Pt 1). 64–79. 37 indexed citations
9.
Paolino, Giovanni, Veronica Huber, Serena Camerini, et al.. (2021). The Fatty Acid and Protein Profiles of Circulating CD81-Positive Small Extracellular Vesicles Are Associated with Disease Stage in Melanoma Patients. Cancers. 13(16). 4157–4157. 20 indexed citations
10.
Nichetti, Federico, Francesca Ligorio, Luca Porcu, et al.. (2021). Risk assessment of thromboembolic events in hospitalized cancer patients. Scientific Reports. 11(1). 18200–18200. 7 indexed citations
11.
Ciliberti, Rosagemma, et al.. (2021). Survey condotta tra gli studenti di Medicina e quelli di Scienze Sociali sulla donazione del corpo a fini di ricerca e didattica. Medicina e Morale. 70(4). 387–408. 2 indexed citations
12.
13.
Verzoni, Elena, Eriomina Shahaj, Simona Frigerio, et al.. (2020). Selective modulation of immune transcripts in extracellular vesicles from plasma of renal cell carcinoma patients receiving nivolumab.. Journal of Clinical Oncology. 38(6_suppl). 719–719. 1 indexed citations
14.
Verzoni, Elena, Simona Ferro, Giuseppe Procopio, et al.. (2018). Potent natural killer (NK) and myeloid blood cell remodeling by cabozantinib (Cabo) in pre-treated metastatic renal cell carcinoma (mRCC) patients (pts). Annals of Oncology. 29. viii312–viii312. 11 indexed citations
15.
Palassini, Elena, Anna Maria Frezza, Luigi Mariani, et al.. (2017). Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis. The Cancer Journal. 23(2). 86–91. 61 indexed citations
16.
Marchianò, Alfonso, María José Cosentino, Giuseppe Di Tolla, et al.. (2017). FNA and CNB in the Diagnosis of Pulmonary Lesions: A Single-center Experience on 665 Patients, Comparison between Two Periods. Tumori Journal. 103(4). 360–366. 6 indexed citations
17.
Bertoglio, Sergio, et al.. (2016). Peripherally inserted central catheters (PICCs) in cancer patients under chemotherapy: A prospective study on the incidence of complications and overall failures. Journal of Surgical Oncology. 113(6). 708–714. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José Mariz Breakdown of academic impact, for papers by J.-L. Houpeau Breakdown of academic impact, for papers by Shunsuke Sugawara Breakdown of academic impact, for papers by Andrew Adamson Breakdown of academic impact, for papers by Barry Hutchinson Breakdown of academic impact, for papers by Güngör Utkan Breakdown of academic impact, for papers by Jong Kil Nam Breakdown of academic impact, for papers by Joanna Rupa‐Matysek Breakdown of academic impact, for papers by V. Milesi Breakdown of academic impact, for papers by Pegge Halandras
Rankless by CCL
2026